Resources for insight and
inspiration
Guides
Insights
Understanding Acceleration: Protecting Startup Talent Through Vesting Strategies
Acceleration is a mechanism in equity compensation that allows employees or founders to vest their stock options faster than the original schedule. It is most often triggered by significant events like a company acquisition. Acceleration ensures that key contributors are fairly compensated during major transitions and protects the value of their equity.
Vesting Schedules: The Strategic Foundation of Startup Equity Compensation
For both founders and employees, vesting schedules are more than a technical requirement. They are a strategic tool that determines how equity is earned, how long employees remain motivated, and how well a startup protects its ownership structure. A well-designed vesting schedule can strengthen retention, build loyalty, and align incentives between the company and its team.
Equity Incentive Plans / Equity Stock Option Plans
For startup founders, an option pool is more than a technical detail - it’s a strategic tool. The size, structure, and timing of your equity incentive plan can determine your ability to attract top talent, align incentives, and keep your company’s cap table clean for future investors.
Option Pools and Acquisitions: Navigating the Equity Landscape
When a startup is acquired, the treatment of its option pool becomes a critical factor for both founders and employees. Option pools influence retention, compensation, and how value is distributed during a merger or acquisition. Understanding what happens to these equity instruments helps founders negotiate better terms and employees make informed financial decisions.
FAQs
Open allNo. It usually excludes fraud, bad faith, or gross negligence. Coverage applies only when actions are taken in good faith within the scope of duties.
Founders, directors, executive officers, and sometimes key advisors.
Yes, but selectively. While ROFR and co-sale rights are often more about governance than daily use, they remain an important safety net for investors.
Yes. Founders often negotiate carve-outs for estate planning transfers, gifts, or small private sales.
ROFR gives the company or investors the right to buy shares before outsiders. Co-sale rights let investors “tag along” and sell their shares alongside a selling shareholder.
Yes. They can include sunset provisions or be amended in later financing rounds to reflect shifts in ownership or company maturity.
Not always. Negotiated terms often leave founders with meaningful board representation, though investors usually gain at least one seat and sometimes an independent director.
It works alongside the Investor Rights Agreement, ROFR and Co-Sale Agreement, and SPA to create a complete governance framework.
Founders, major investors, and sometimes key employees sign the Voting Agreement as part of a priced equity round.
Yes. Founders can negotiate reporting frequency, pro rata thresholds, and board seat limits to ensure rights are appropriate for the company’s stage.
Registration rights only come into play if the company goes public. They give investors the right to sell their shares in the IPO or subsequent offerings.
The SPA governs the actual purchase of shares, while the IRA governs post-investment rights like information access, pro rata participation, and registration rights.
Not usually. Most rights are limited to “major investors” who meet certain thresholds, preventing administrative complexity from smaller shareholders.
Yes. Some SPAs allow staged investments or additional closings if investors commit to fund in tranches.
If misstatements are discovered, investors may have indemnification claims, meaning the company (or founders in some cases) could be liable.
Yes, all participating investors sign the SPA, along with the company. It governs the purchase of shares in that financing round.
The term sheet is a non-binding summary of key deal points. The SPA is the binding agreement that formalizes the transaction and contains detailed legal terms.
Seed-stage caps often fall between $3M and $10M, but terms vary widely depending on market conditions, industry, and company traction.
Low caps can create significant dilution when notes or SAFEs convert, especially if the company grows rapidly before a priced round.